CME Group (CME): Director sold ~$121K

~$121K

Approx. value · 400 sh @ $302.50

25K

Holds after · shares reported

Traded

Oct 22, 2026

Filed

Oct 22, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“As described in the attached press release, CME Group Inc. (“CME Group” or the “Company”) announced new senior leadership appointments in its finance and legal divisions.”
2. Sep 10, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
3. Sep 14, 2026InsiderDirector sold ~$140K of CME shares in the open market
4. Sep 24, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
5. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
6. Oct 22, 2026 · this disclosureInsiderDirector sold ~$121K of CME shares in the open market

What came next

1. Oct 27, 2026InsiderOfficer sold ~$1.49M of CME shares in the open market
2. Nov 2, 2026Insider · 2 peopleInsiders: 2 sales (~$3.7M)
3. Nov 9, 2026InsiderDirector sold ~$162K of CME shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for CME Group

For CME Group, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.

Other recent filings by Martin J Gepsman, Director

• SEC Form 4 at CME Group (CME)Feb 20, 2026
• SEC Form 4 at CME Group (CME)May 19, 2025
• SEC Form 4 at CME Group (CME)Nov 5, 2024

The full history of Martin J Gepsman, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at CME Group

• SEC Form 13F-HRNov 13, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 4Nov 3, 2026
• SEC Form 4Nov 3, 2026
• SEC Form 144Nov 2, 2026

Everything OQRO holds on this company is on its CME page.